Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
Southern Medical Journal|June 1, 1987
Theophylline disposition in tetraplegic manJ L Segal, S K Gordon, I M EltoraiPharmacotherapy|January 1, 1988
Amikacin pharmacokinetics in patients with spinal cord injuryJ L Segal, S R Brunnemann, S K Gordon, et al.Pharmacotherapy|January 1, 1986
The absolute bioavailability of oral theophylline in patients with spinal cord injuryJ L Segal, S R Brunnemann, S K Gordon, et al.Paraplegia|February 1, 1985
Gentamicin disposition kinetics in humans with spinal cord injuryJ L Segal, D R Gray, S K Gordon, et al.Antimicrobial Agents and Chemotherapy|July 1, 1990
Pharmacokinetics of amikacin in serum and in tissue contiguous with pressure sores in humans with spinal cord injuryJ L Segal, S R Brunnemann, I M EltoraiJournal of Clinical Pharmacology|July 1, 1991
Decreased systemic clearance of lorazepam in humans with spinal cord injuryJ L Segal, S R Brunnemann, I M Eltorai, et al.The Journal of Spinal Cord Medicine|July 29, 2000
Sigmoid colon rupture secondary to Credé's method in a patient with spinal cord injuryR K Rajan, G Juler, I M EltoraiPostgraduate Medicine|August 1, 1980
Hypertensive emergencies: practical approach to treatmentJ L SegalThe Journal of the American Paraplegia Society|July 1, 1993
Fibrinolytic and protease inhibitory systems in spinal cord injured patients with end-stage renal diseaseN D Vaziri, R L Winer, E V Gonzales, et al.Pageof 5